(Bloomberg) — CVS Health Corp. shares gained in premarket trading Wednesday after the health-care conglomerate projected strong 2020 sales, driven by growth in its pharmacy-benefit management business.In an investor presentation, CVS said it sees 2020 revenue between $261.97 billion and $265.48 billion, above Wall Street analysts’ average expectation of $256.89 billion.Key InsightsIn the fourth quarter, the pharmacy-services segment brought in $37.1 billion. In 2020, CVS expects the business will have revenue of $137.50 billion to $139.45 billion, more than the $136.01 billion analysts expect. The business has been a cornerstone of CVS’s growth despite growing criticism of the industry’s role …read more
Source:: Yahoo Finance
